Skip NavigationSkip to Content

PanoromiX: a time-course network medicine platform integrating molecular assays and pathophenotypic data

  1. Author:
    Yang, Ruoting
    Watson, Daniel
    Williams, Joshua
    Kumar, Raina
    Campbell, Ross
    Mudunuri, Uma
    Hammamieh, Rasha
    Jett, Marti
  2. Author Address

    Frederick Natl Lab Canc Res, Adv Biomed Computat Sci, Frederick, MD 21702 USA.US Army, Ctr Environm Hlth Res, Integrat Syst Biol Program, 568 Doughten Dr, Ft Detrick, MD 21702 USA.
    1. Year: 2018
    2. Date: Nov 29
  1. Journal: BMC BIOINFORMATICS
  2. BMC,
    1. 19
  3. Type of Article: Article
  4. Article Number: 458
  5. ISSN: 1471-2105
  1. Abstract:

    BackgroundNetwork medicine aims to map molecular perturbations of any given diseases onto complex networks with functional interdependencies that underlie a pathological phenotype. Furthermore, investigating the time dimension of disease progression from a network perspective is key to gaining key insights to the disease process and to identify diagnostic or therapeutic targets. Existing platforms are ineffective to modularize the large complex systems into subgroups and consolidate heterogeneous data to web-based interactive animation.ResultsWe have developed PanoromiX platform, a data-agnostic dynamic interactive visualization web application, enables the visualization of outputs from genome based molecular assays onto modular and interactive networks that are correlated with any pathophenotypic data (MRI, Xray, behavioral, etc.) over a time course all in one pane. As a result, PanoromiX reveals the complex organizing principles that orchestrate a disease-pathology from a gene regulatory network (nodes, edges, hubs, etc.) perspective instead of snap shots of assays. Without extensive programming experience, users can design, share, and interpret their dynamic networks through the PanoromiX platform with rich built-in functionalities.ConclusionsThis emergent tool of network medicine is the first to visualize the interconnectedness of tailored genome assays to pathological networks and phenotypes for cells or organisms in a data-agnostic manner. As an advanced network medicine tool, PanoromiX allows monitoring of panel of biomarker perturbations over the progression of diseases, disease classification based on changing network modules that corresponds to specific patho-phenotype as opposed to clinical symptoms, systematic exploration of complex molecular interactions and distinct disease states via regulatory network changes, and the discovery of novel diagnostic and therapeutic targets.

    See More

  1. Keywords:

External Sources

  1. DOI: 10.1186/s12859-018-2494-6
  2. PMID: 30497372
  3. WOS: 000451684500003

Library Notes

  1. Fiscal Year: FY2018-2019
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel